Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

GRFS

Grifols SA ADR

Dec 13 • 04:00PM ET

7.33

Dollar change -0.27
Percentage change -3.55	%

Healthcare • Drug Manufacturers - General • Spain • NASD

Peers: JNJ BMY PFE MRK LLY AMGN GILD BAX ABT CANF

| Held by: IBB KOMP BINV SPDW BSMC APIE ONEQ TFPN CGIC BIB

Scroll to Statements

Index	-	P/E	29.23	EPS (ttm)	0.25	Insider Own	0.06%	Shs Outstand	257.44M	Perf Week	0.41%
Market Cap	1.89B	Forward P/E	7.44	EPS next Y	0.99	Insider Trans	0.00%	Shs Float	257.30M	Perf Month	-19.36%
Income	170.26M	PEG	0.50	EPS next Q	-	Inst Own	55.44%	Short Float	1.49%	Perf Quarter	-20.67%
Sales	7.11B	P/S	0.27	EPS this Y	84.09%	Inst Trans	11.73%	Short Ratio	3.84	Perf Half Y	4.71%
Book/sh	8.82	P/B	0.83	EPS next Y	49.63%	ROA	0.27%	Short Interest	3.83M	Perf Year	-30.12%
Cash/sh	2.80	P/C	2.62	EPS next 5Y	58.37%	ROE	0.99%	52W Range	5.30 - 12.15	Perf YTD	-36.59%
Dividend Est.	0.02 (0.32%)	P/FCF	-	EPS past 5Y	-37.97%	ROI	1.08%	52W High	-39.67%	Beta	0.42
Dividend TTM	-	Quick Ratio	0.79	Sales past 5Y	6.28%	Gross Margin	38.05%	52W Low	38.30%	ATR (14)	0.39
Dividend Ex-Date	Jun 03, 2021	Current Ratio	2.26	EPS Y/Y TTM	-23.44%	Oper. Margin	13.06%	RSI (14)	39.23	Volatility	4.28% 4.17%
Employees	23744	Debt/Eq	1.84	Sales Y/Y TTM	-	Profit Margin	2.40%	Recom	2.75	Target Price	12.31
Option/Short	Yes / Yes	LT Debt/Eq	1.65	EPS Q/Q	-	Payout	0.00%	Rel Volume	0.86	Prev Close	7.60
Sales Surprise	-6.10%	EPS Surprise	-26.24%	Sales Q/Q	8.80%	Earnings	Nov 07 AMC	Avg Volume	996.61K	Price	7.33
SMA20	-7.51%	SMA50	-13.48%	SMA200	-4.54%	Trades		Volume	856,087	Change	-3.55%

Date	Action	Analyst	Rating Change
Mar-12-24	Downgrade	Deutsche Bank	Hold → Sell
Apr-12-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Mar-03-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Feb-16-23	Upgrade	Barclays	Underweight → Equal Weight
Jan-18-23	Upgrade	Jefferies	Hold → Buy
Apr-08-22	Initiated	Morgan Stanley	Equal-Weight
Nov-05-21	Downgrade	Deutsche Bank	Buy → Hold
Oct-19-21	Downgrade	Barclays	Overweight → Underweight
Oct-06-21	Upgrade	Citigroup	Neutral → Buy
Jun-14-21	Upgrade	Deutsche Bank	Hold → Buy
Apr-20-21	Initiated	Deutsche Bank	Hold
Mar-23-21	Upgrade	Credit Suisse	Neutral → Outperform
Mar-11-21	Upgrade	HSBC Securities	Hold → Buy
Oct-01-20	Upgrade	Citigroup	Sell → Neutral
Jun-09-20	Upgrade	HSBC Securities	Reduce → Hold
Jun-09-20	Downgrade	Citigroup	Neutral → Sell
Mar-25-20	Downgrade	Citigroup	Buy → Neutral
Jun-27-19	Upgrade	JP Morgan	Neutral → Overweight
Feb-08-19	Downgrade	Berenberg	Buy → Hold
Oct-11-18	Upgrade	Berenberg	Hold → Buy

Show Previous Ratings

Dec-13-24 05:24AM	Grifols Worst-Ever Year Cant Derail Analyst Calls to Buy (Bloomberg)
04:14AM	Grifols Keeps Door Open to Brookfield With Special Bond Term (Bloomberg)
Dec-10-24 01:07PM	Flat Footed Asks Grifols to Reform Board to Protect Shareholders (Bloomberg)
Dec-06-24 10:34AM	Analyst Report: Grifols, S.A. (Morningstar Research)
Dec-05-24 03:40AM	SEC Drops Probe Into Gotham Over Report on Grifols Accounts (Bloomberg)
02:30AM	Loading…
Dec-04-24 02:30AM	Mason Capital Management Requests Immediate Disclosure of Important Information Regarding Conflicted Grifols Director Tomas Daga (Business Wire)
Dec-03-24 05:13AM	Grifols Shareholder Mason Capital Calls for Board Overhaul (Bloomberg)
Nov-29-24 09:29AM	Why Is Spanish Healthcare Grifols Stock Trading Lower On Friday? (Benzinga) -13.38%
Nov-28-24 07:39AM	Billionaire Grifols Family Woes in Focus as Brookfield Exits (Bloomberg)
07:09AM	Grifols In Talks to Refinance Debt, Credit Line, CEO Says (Bloomberg)
Nov-27-24 09:02AM	Brookfield Drops $6.8 Billion Offer to Buy Drugmaker Grifols (Bloomberg) -7.45%
06:58AM	Brookfield Set to Drop Grifols Bid as Family Shuns Others (Bloomberg)
Nov-20-24 07:30AM	GigaGen commences Phase I clinical trial of GIGA-2339 for hepatitis B treatment (Clinical Trials Arena)
02:16AM	Grifols Signals It Would Reject $6.8 Billion Brookfield Bid (Bloomberg)
Nov-19-24 11:16PM	Analyst Report: Grifols, S.A. (Morningstar Research) -8.24%
08:00AM	Loading…
08:00AM	GigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B Virus (GlobeNewswire)
07:33AM	Brookfield Weighs 6.45 Billion Bid for Grifols; Shares Drop (Bloomberg)
02:30AM	Mason Capital Reiterates Corporate Governance Shortcomings and Mismanagement of Grifols Under Current Board of Directors (Business Wire)
Nov-14-24 11:37AM	Banks to Pitch Roughly 11 Billion Buyout Debt for Grifols (Bloomberg) +5.06%
Nov-08-24 06:01PM	Grifols SA (GIFLF) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Improved Cash ... (GuruFocus.com)
03:54PM	Mason Capital Management Highlights Corporate Governance Failures and Significant Shareholder Value Destruction Under Grifols Board of Directors (Business Wire)
10:27AM	Analyst Report: Grifols, S.A. (Morningstar Research)
Nov-05-24 12:02PM	Brookfield Seeks More Information on Grifols Related-Party Deals (Bloomberg) +5.57%
Oct-30-24 08:28AM	Grifols receives FDA approval to treat surgical bleeding with FS solution (TipRanks) +6.95%
Oct-29-24 08:00AM	Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution (GlobeNewswire)
Oct-22-24 08:00AM	Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury (GlobeNewswire)
Oct-03-24 08:00AM	GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat (GlobeNewswire)
Sep-19-24 04:00PM	Grifols Investor Group With 7.7% Holding Seeks Seat on Board (Bloomberg)
Sep-10-24 01:37PM	Grifols Holders Call on Family, Brookfield to Offer Fair Price (Bloomberg)
Sep-03-24 05:41AM	Grifols Postpones Capital Markets Day Amid Potential Takeover (Bloomberg)
12:22PM	Loading…
Aug-29-24 12:22PM	Brookfield Courts Sovereign Funds to Join Grifols Takeover Bid (Bloomberg)
Aug-26-24 07:00AM	This Reviled Pharmaceutical Firm Holds Promise of a Healthier Future (The Wall Street Journal)
Aug-22-24 11:01AM	Why Grifols (GRFS) Stock Price Moved Up 7% on Wednesday (Zacks) +15.38%
Aug-21-24 12:19PM	Brookfield in talks with banks for funding Grifols' takeover bid, sources say (Reuters) +6.68%
05:33AM	Brookfield Seeks Nearly 10 Billion to Back Grifols Takeover (Bloomberg)
05:14AM	Grifols shares up on potential takeover by Brookfield (Investing.com)
Aug-07-24 07:02PM	Azvalor Iberia FI's Strategic Moves in Q2 2024: Spotlight on Linea Directa Aseguradora SA (GuruFocus.com)
Aug-02-24 01:21PM	Grifols S.A. (GRFS) Admits Improper Accounting, Announces Restatements, Shares Decline Again - Hagens Berman (Business Wire)
Jul-31-24 12:27PM	Grifols: Q2 Earnings Snapshot (Associated Press Finance)
08:00AM	GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HBV Treatment, GIGA-2339 (GlobeNewswire)
Jul-30-24 07:42PM	Analyst Report: Grifols, S.A. (Morningstar Research)
11:35AM	Grifols Cuts Chinese Stake Value by 457 Million After Audit (Bloomberg)
Jul-29-24 08:00AM	Grifols receives expanded XEMBIFY (immune globulin subcutaneous human-klhw) label in U.S., strengthening its Ig portfolio for patients (GlobeNewswire)
Jul-09-24 11:28AM	Grifols Family Shareholders, Brookfield in Talks To Take Firm Private (Investopedia)
Jul-08-24 01:00PM	3 Stocks to Buy From the Ultimate' Buy-and-Hold Portfolio (InvestorPlace) +19.46%
12:36PM	GRFS Stock Alert: Grifols Pops 20% on Takeover Interest (InvestorPlace)
11:36AM	Analyst Report: Grifols, S.A. (Morningstar Research)
11:16AM	Beleaguered Spanish Drug Firm Grifols Stock Jumps On Monday - Here's Why (Benzinga)
07:41AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace)
06:18AM	Grifols Says Founding Family, Brookfield Weigh Takeover Bid (Bloomberg)
Jul-01-24 06:00AM	Grifols' Biotest to achieve USD 1 billion in US sales of Yimmugo over next seven years (GlobeNewswire)
Jun-18-24 07:30AM	Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group (GlobeNewswire)
Jun-17-24 11:54AM	Biotest wins FDA approval for plasma protein therapy (Pharmaceutical Technology)
10:13AM	Grifols prepares for late-stage plans with plasma-derived medicines in 2024 (Pharmaceutical Technology)
04:20AM	Grifols' Biotest receives FDA approval for innovative Yimmugo immunoglobulin to treat primary immunodeficiencies (GlobeNewswire)
Jun-07-24 03:32PM	Analyst Report: Grifols, S.A. (Morningstar Research)
May-21-24 04:31AM	GigaGen doses first subject in Phase I advanced solid tumour trial (Clinical Trials Arena)
May-20-24 08:07AM	Grifols, S.A. (NASDAQ:GRFS) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:00AM	GigaGen Doses First Patient in Phase 1 Trial of Anti-CTLA-4 Oncology Drug Candidate GIGA-564 in Advanced Solid Tumors (GlobeNewswire)
May-14-24 06:02PM	Analyst Report: Grifols, S.A. (Morningstar Research)
May-09-24 10:07AM	Short Seller Gains on Grifols Bet That Tripped Elliott Spinout (Bloomberg)
May-06-24 12:18PM	Grifols Shares Rise as Haier Deal Set to Close in June (MT Newswires) +6.85%
Apr-19-24 04:42PM	Grifols 2023 Annual Report on Form 20-F filed with the SEC (PR Newswire)
Apr-18-24 09:30AM	Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C. (GlobeNewswire)
Apr-14-24 07:16AM	Spanish drug maker Grifols will bring in independent directors, chairman tells newspaper (Reuters)
Apr-10-24 04:01AM	Grifols Plans First Bond Sale Since Short Seller Attack (Bloomberg)
Apr-04-24 04:00AM	Grifols Procleix ArboPlex Assay Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening (GlobeNewswire)
Mar-29-24 02:11PM	Grifols S.A. (GRFS ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another Critical Report Hagens Berman (GlobeNewswire)
Mar-25-24 01:25PM	Grifols S.A. (GRFS ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another Critical Report Hagens Berman (GlobeNewswire)
Mar-22-24 08:03AM	Grifols Drops as Regulator Finds Relevant Deficiencies (Bloomberg) -8.26%
Mar-20-24 01:21PM	Grifols S.A. (GRFS ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another Critical Report Hagens Berman (GlobeNewswire)
Mar-08-24 06:25PM	Analyst Report: Grifols, S.A. (Morningstar Research) +24.78%
12:34PM	Health Care Roundup: Market Talk (The Wall Street Journal)
05:06AM	UPDATE 2-Europe's STOXX 600 logs weekly gains, US jobs data in focus (Reuters)
Mar-06-24 06:29PM	Analyst Report: Grifols, S.A. (Morningstar Research) -11.35%
03:21PM	Spanish Healthcare Firm Grifols Hit With New Gotham City's Short Report, Faces Questions Regarding Transparency, Integrity, Ethical Conduct (Benzinga)
Feb-29-24 03:51PM	Analyst Report: Grifols, S.A. (Morningstar Research) -19.59%
02:04PM	Grifols Drops 35% as Management Flags Risk of Zero Cash Flow (Bloomberg)
Feb-21-24 11:32AM	Activists Load Up on Temenos, Grifols After Short Seller Reports (Bloomberg)
Feb-14-24 03:16AM	Grifols announces positive topline phase 3 fibrinogen clinical trial results (GlobeNewswire)
Feb-12-24 11:56AM	Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report Hagens Berman (GlobeNewswire)
07:03AM	Charles Brandes Adjusts Position in Grifols SA (GuruFocus.com)
07:03AM	Charles Brandes Bolsters Position in Grifols SA (GuruFocus.com)
Feb-08-24 01:02PM	Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report Hagens Berman (GlobeNewswire)
Feb-05-24 09:55AM	Here's Why Grifols (GRFS) Is a Great 'Buy the Bottom' Stock Now (Zacks)
Feb-01-24 08:05PM	Grifols S.A.: Company Investigated by the Portnoy Law Firm (GlobeNewswire)
10:15AM	Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report Hagens Berman (GlobeNewswire)
Jan-26-24 02:49PM	UPDATE 1-Spain's Grifols sues Gotham City fund, JV over damaging report (Reuters)
02:01PM	Grifols Sues Gotham City Over False Short-Seller Report (Bloomberg)
01:03PM	Spain's Grifols sues Gotham City fund, JV over damaging report (Reuters)
Jan-25-24 12:24PM	Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report Hagens Berman (GlobeNewswire)
Jan-23-24 05:05PM	Health Care Roundup: Market Talk (The Wall Street Journal)
Jan-19-24 12:32PM	Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report Hagens Berman (GlobeNewswire)
Jan-18-24 08:36AM	ECB Asks Banks for Details About Exposure to Spains Grifols (Bloomberg)
Jan-17-24 05:44AM	Grifols Analyst Breaks Ranks With Peers After Short Seller Chaos (Bloomberg) -7.50%
Jan-16-24 05:39PM	Grifols S.A. (GRFS) Plummets After Gotham City Research Questions Accounting Hagens Berman (GlobeNewswire)
Jan-15-24 09:35AM	Here's Why Grifols (GRFS) is Poised for a Turnaround After Losing -31.55% in 4 Weeks (Zacks)
Jan-14-24 03:16PM	Grifols Says Haier Has Offered Reassurance on China Deal (Bloomberg)
03:06PM	Grifols says Haier Group still OK to buy stake in Shanghai RAAS (Reuters)
Jan-12-24 12:16PM	Grifols shares suffer worst week on record after short-seller report (Reuters) -11.68%

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by Jose Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GRFS

Grifols SA ADR

Upgrade your FINVIZ experience